CX Institutional’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.63M Sell
11,529
-1,031
-8% -$325K 0.1% 184
2026
Q1
$4.13M Sell
12,560
-498
-4% -$179K 0.13% 177
2025
Q4
$4.59M Buy
13,058
+1,015
+8% +$370K 0.14% 153
2025
Q3
$4.45M Buy
12,043
+7,962
+195% +$3.08M 0.14% 153
2025
Q2
$1.61M Buy
4,081
+66
+2% +$24.7K 0.06% 212
2025
Q1
$1.5M Sell
4,015
-95
-2% -$36.2K 0.06% 225
2024
Q4
$1.48M Buy
4,110
+632
+18% +$234K 0.06% 207
2024
Q3
$1.26M Buy
3,478
+130
+4% +$44.9K 0.06% 253
2024
Q2
$1.14M Sell
3,348
-21
-0.6% -$7.11K 0.05% 261
2024
Q1
$1.21M Sell
3,369
-114
-3% -$38.4K 0.06% 254
2023
Q4
$1.04M Sell
3,483
-211
-6% -$59.2K 0.06% 251
2023
Q3
$1.01M Sell
3,694
-60
-2% -$17.2K 0.06% 251
2023
Q2
$1.15M Buy
3,754
+113
+3% +$32.6K 0.06% 259
2023
Q1
$1.05M Buy
3,641
+1,022
+39% +$271K 0.06% 270
2022
Q4
$640K Buy
2,619
+898
+52% +$204K 0.04% 338
2022
Q3
$349K Buy
1,721
+801
+87% +$168K 0.02% 375
2022
Q2
$183K Sell
920
-462
-33% -$109K 0.01% 451
2022
Q1
$369K Buy
1,382
+72
+5% +$18.6K 0.03% 291
2021
Q4
$350K Sell
1,310
-53
-4% -$13.9K 0.03% 274
2021
Q3
$359K Buy
1,363
+80
+6% +$21.4K 0.03% 294
2021
Q2
$333K Buy
1,283
+205
+19% +$52.4K 0.03% 288
2021
Q1
$263K Sell
1,078
-190
-15% -$45.6K 0.02% 274
2020
Q4
$311K Sell
1,268
-1,352
-52% -$306K 0.03% 264
2020
Q3
$546K Buy
2,620
+1,405
+116% +$273K 0.06% 199
2020
Q2
$219K Buy
1,215
+219
+22% +$40.4K 0.03% 238
2020
Q1
$166K Sell
996
-58
-6% -$11.3K 0.03% 240
2019
Q4
$221K Sell
1,054
-114
-10% -$23.7K 0.04% 190
2019
Q3
$253K Buy
1,168
+7
+0.6% +$1.5K 0.04% 202
2019
Q2
$239K Sell
1,161
-150
-11% -$28.6K 0.04% 207
2019
Q1
$259K Buy
1,311
+291
+29% +$52.4K 0.05% 192
2018
Q4
$160K Buy
1,020
+5
+0.5% +$836 0.03% 180
2018
Q3
$180K Sell
1,015
-30
-3% -$5.12K 0.06% 122
2018
Q2
$176K Buy
+1,045
New +$176K 0.07% 118

Other funds holding SYK

CX Institutional's SYK Position: Q2 2026 in Review

CX Institutional reduced its Stryker (SYK) stake by 8.2% in Q2 2026, selling an estimated $325K and leaving 11,529 shares worth $3.63M. The position accounts for 0.1% of the portfolio, ranked #184.

CX Institutional first reported a position in SYK in Q2 2018 and has held it in 33 quarters since. The position peaked at $4.59M in Q4 2025. 788 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

  • CX Institutional held 11,529 shares of Stryker worth $3.63M as of Q2 2026.
  • CX Institutional sold 1,031 Stryker shares in Q2 2026, an estimated $325K.
  • Stryker made up 0.1% of CX Institutional's portfolio in Q2 2026, its #184 holding.
  • CX Institutional first reported a position in Stryker in Q2 2018 and has held it in 33 quarters since.
  • CX Institutional's Stryker position peaked at $4.59M in Q4 2025.
  • 788 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.